Summary & Overview
HCPCS S2267: Induced Abortion, 32 Weeks or Greater
HCPCS Level II code S2267 designates an induced abortion at 32 weeks gestation or later, a late-term obstetric surgical procedure typically performed in an inpatient hospital or similarly equipped facility. This code matters nationally because it captures high-acuity, time-sensitive care with significant clinical, legal, and reimbursement implications across payers. Accurate use of S2267 affects claims processing, coverage determinations, and quality reporting for advanced obstetric services.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a national overview of coverage and billing contexts for late-term induced abortion services, including typical sites of service, expected claim considerations, and common procedural context. The publication outlines benchmark topics such as utilization patterns, coding accuracy issues, and payer policy considerations, and summarizes relevant clinical context without state-specific guidance.
The report provides guidance on interpreting S2267 on claims, highlights areas where additional documentation is often required, and identifies where data was not provided in the input. Data not available in the input will be noted where relevant.
Billing Code Overview
HCPCS Level II code S2267 represents induced abortion, 32 weeks or greater. This code denotes a late-term induced termination of pregnancy performed at or beyond 32 weeks of gestation. The service type is a surgical/obstetric procedure related to pregnancy termination. The typical site of service is an inpatient hospital or other facility equipped for advanced obstetric surgical care.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a pregnant individual at or beyond 32 weeks' gestation presenting for an induced termination of pregnancy due to severe fetal anomaly incompatible with life (for example, anencephaly or trisomy incompatible with neonatal survival), maternal health risk from continuing the pregnancy (for example, severe preeclampsia with impending eclampsia), or other legally and medically supported indications. The clinical workflow includes antenatal counseling by maternal-fetal medicine or obstetrics providers, informed consent, preoperative evaluation (laboratory studies, Rh immunoglobulin assessment, ultrasound confirmation of gestational age and fetal condition), and arranging the appropriate inpatient setting.
The procedure is typically performed in an inpatient hospital or licensed ambulatory surgical center with capacity for late-gestation obstetric procedures. An obstetrician-gynecologist, often with additional training in maternal-fetal medicine, leads the procedure team. Anesthesia may be regional (epidural/spinal) or general based on clinical needs. The workflow includes induction of labor or operative induction techniques, fetal and placental management per hospital protocols, hemorrhage preparedness, access to blood products, and postpartum monitoring. Documentation must include gestational age (≥32 weeks), indication for induction, informed consent, method of induction, anesthetic record, operative notes if applicable, and post-procedure disposition and complications management.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 |